Myovant Sciences Ltd (MYOV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 03/31
| 06-2020 | 03-2020 | 12-2019 | 09-2019 | 06-2019 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 84,726 | 76,644 | 83,073 | 130,373 | 226,734 |
| Marketable Securities | 14,970 | 2,997 | 15,815 | 27,220 | N/A |
| Receivables | N/A | N/A | N/A | 17 | 331 |
| TOTAL | $109,066 | $87,910 | $110,974 | $167,579 | $235,758 |
| Non-Current Assets | |||||
| PPE Net | 2,453 | 2,497 | 2,406 | 2,288 | 2,057 |
| Other Non-Current Assets | 15,163 | 15,519 | 16,127 | 14,135 | 13,058 |
| TOTAL | $17,616 | $18,016 | $18,533 | $16,423 | $15,115 |
| Total Assets | $126,682 | $105,926 | $129,507 | $184,002 | $250,873 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | N/A | N/A | 8,402 | 10,867 |
| Accounts payable and accrued liabilities | 5,412 | 15,349 | 6,633 | 6,395 | 10,958 |
| Accrued Expenses | 28,920 | 29,060 | 45,214 | 44,380 | 46,258 |
| TOTAL | $52,584 | $85,925 | $53,296 | $60,030 | $68,896 |
| Non-Current Liabilities | |||||
| Long Term Debt | 193,700 | 113,700 | 113,700 | 92,075 | 89,070 |
| Deferred Revenues | 16,667 | 40,000 | N/A | N/A | N/A |
| Other Non-Current Liabilities | 15,008 | 14,578 | 11,399 | 14,643 | 13,340 |
| TOTAL | $208,708 | $128,278 | $125,099 | $106,718 | $102,410 |
| Total Liabilities | $261,292 | $214,203 | $178,395 | $166,748 | $171,306 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 90,149 | 89,869 | 89,788 | 89,624 | 89,623 |
| Common Shares | 2 | 2 | 2 | 2 | 2 |
| Retained earnings | -823,874 | -791,014 | -726,101 | -640,497 | -569,929 |
| Other shareholders' equity | -5,121 | -1,646 | -823 | -31 | -312 |
| TOTAL | $-134,610 | $-108,277 | $-48,888 | $17,254 | $79,567 |
| Total Liabilities And Equity | $126,682 | $105,926 | $129,507 | $184,002 | $250,873 |